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The P2Y4 receptor is selectively activated by UTP.
Although addition of neither ATP nor UDP alone in-
creased intracellular Ca21 in 1321N1 human astrocy-
toma cells stably expressing the P2Y4 receptor, com-
bined addition of these nucleotides resulted in a slowly
occurring elevation of Ca21. The possibility that the
stimulatory effect of the combined nucleotides reflected
formation of UTP by an extracellular transphosphoryl-
ating activity was investigated. Incubation of cells with
[3H]UDP or [3H]ADP under conditions in which cellular
release of ATP occurred or in the presence of added ATP
resulted in rapid formation of the corresponding
triphosphates. Transfer of the g-phosphate from
[g-33P]ATP to nucleoside diphosphates confirmed that
the extracellular enzymatic activity was contributed by
a nucleoside diphosphokinase. The majority of this ac-
tivity was associated with the cell surface of 1321N1
cells, suggesting involvement of an ectoenzyme. Both
ADP and UDP were effective substrates for transphos-
phorylation. Since ecto-nucleotidase(s) has been consid-
ered previously to be the primary enzyme(s) responsible
for metabolism of extracellular nucleotides, the relative
rates of hydrolysis of ATP, ADP, UTP, and UDP also
were determined for 1321N1 cells. All four nucleotides
were hydrolyzed with similar Km and Vmax values. Ki-
netic analyses of the ecto-nucleoside diphosphokinase
and ecto-nucleotidase activities indicated that the rate
of extracellular transphosphorylation exceeds that of
nucleotide hydrolysis by up to 20-fold. Demonstration of
the existence of a very active ecto-nucleoside diphos-
phokinase together with previous observations that
stress-induced release of ATP occurs from most cell
types indicates that transphosphorylation is physiolog-
ically important in the extracellular metabolism of ade-
nine and uridine nucleotides. Since the P2Y receptor
class of signaling proteins differs remarkably in their
respective specificity for adenine and uridine nucleo-
tides and di- and triphosphates, these results suggest
that extracellular interconversion of adenine and uri-
dine nucleotides plays a key role in defining activities in
nucleotide-mediated signaling.
The importance of adenine nucleotides as extracellular sig-
naling molecules is well established (1, 2). ATP and/or ADP are
released in a regulated fashion from neurons, platelets, and
other cells and interact with two major classes of cell surface
receptors, the ligand-gated P2X receptors and the G protein-
coupled P2Y receptors (3–5). These receptors, which are en-
coded by at least a dozen different genes, in turn promote an
exceptionally broad range of functional responses. Although
physiologically important release of uridine nucleotides is less
well defined, the identification of at least three P2Y receptors
that are selectively activated by low concentrations of UTP or
UDP is consistent with an important extracellular signaling
role for pyrimidines (5, 6).
Hydrolysis by ecto-nucleotidases provides a mechanism
whereby the physiological effects of extracellular nucleotides
are terminated (2, 7–9). Degradation of ATP and ADP also
apparently serves as a major source of extracellular adenosine,
which in turn activates A1, A2, and A3 adenosine receptors
(10). The enzymatic species involved in hydrolysis of extracel-
lular nucleotides have not been unambiguously defined, al-
though certain ATP-diphosphohydrolases exhibiting kinetic
properties consistent with those of physiologically relevant
ecto-nucleotidases have been purified and/or cloned (11, 12).
The possibility that other types of ectoenzymes contribute to
the metabolism and/or interconversion of extracellular adenine
and uridine nucleotides has not been considered extensively.
Nucleoside diphosphokinase (NDPK)1 catalyzes the trans-
phosphorylation of nucleoside diphosphates utilizing nucleo-
side triphosphates as the g-phosphate donor (13). Intracellular
NDPK fulfills a crucial role in maintaining the high energy
phosphate bond in ATP as part of the citric acid chain. NDPK
also has been proposed to play a major role in the cytosolic
synthesis of nucleoside triphosphates in addition to ATP and in
maintaining a relative balance in the concentrations of nucle-
oside triphosphates. Human nm23 genes encode for nucleoside
diphosphokinases (14, 15), and an inverse relationship exists
between nm23 expression and metastatic potential (16, 17).
In contrast to its well established significance in intermedi-
ary metabolism, the potential location and function of NDPK as
an extracellular enzyme involved in the transfer of terminal
phosphates between extracellular nucleotides has not been de-
termined. Therefore, we have tested this possibility using
1321N1 human astrocytoma cells stably expressing the P2Y4
receptor which we show is selectively activated by UTP. Extra-
cellular conversion of UDP to UTP has been measured in the
presence of ATP, and P2Y4 receptor-promoted elevation of in-
tracellular Ca21 has been quantitated as a functional measure
of this conversion. Accordingly, we have identified an ecto-
NDPK activity associated with 1321N1 cells that, in the pres-
ence of a g-phosphate donor, promotes formation of UTP or
ATP from their corresponding diphosphate nucleotides. The
activity of this enzyme exceeds that of the ecto-nucleotidase
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activity by 20-fold. Thus, NDPK activity promotes active inter-
change of g-phosphates between endogenous adenine and uri-
dine nucleotides on the surface of 1321N1 cells, and this inter-
conversion has significant implications in establishing
selectivity of activation of P2Y receptors which differ markedly
in their nucleoside diphosphate and triphosphate specificity.
MATERIALS AND METHODS
Cell Culture—Wild type 1321N1 human astrocytoma cells and
1321N1 cells infected with retrovirus harboring the P2Y4 receptor se-
quence (provided by Dr. R. Nicholas and Dr. J. Schachter) were cultured
in DMEM-high glucose (DMEM-H) medium supplemented with 5%
fetal bovine serum and antibiotics as described (18). The cells were
grown to confluence on 24-well plastic plates (except where indicated
otherwise) for nucleotide metabolism studies or on 25-mm glass cover-
slips previously coated with 0.3 mg/ml vitrogen for calcium
measurements.
Measurement of Intracellular Ca21—P2Y4 receptor-expressing cells
were incubated with 3 mM Fura-2/AM for 30 min at 37 °C. After the
loading period, the cells were bathed in 0.4 ml of Ringer solution (130
mM NaCl, 5 mM KCl, 1.3 mM CaCl2, 1.3 mM MgCl2, 5 mM glucose, and
10 mM HEPES, pH 7.4) and mounted in a microscope chamber. The
fluorescence (.450 nm) of 30–50 cells was alternately determined at
340 and 380 nm excitation by a RatioMaster RM-D microscope fluorim-
etry system (Photon Technology Inc., Monmouth Junction, NJ) at room
temperature. A Zeiss Axiovert 35 inverted microscope and Nikon UV-F
1003/1.30 glycerol immersion objective were used. After each experi-
ment, the cells were lysed with 40 mM digitonin, and the background
fluorescence was determined by quenching with 4 mM manganese. The
background-corrected ratio values (340/380) were calibrated by using
the formula originally proposed by Grynkiewicz et al. (19). Rmax, Rmin,
and Kd values were determined by using 1 mM Fura-2 free acid and a
series of Ca21 buffers.
Metabolism of Nucleotides by 1321N1 Cells—The cells were washed
three times with serum-free DMEM medium and bathed in 0.5 ml of
DMEM-H/HEPES, pH 7.4. Incubations were initiated by the addition of
drugs and terminated by transferring the medium to a tube containing
50 ml of 50 mM EDTA and subsequently boiled for 1 min. The samples
were maintained at 220 °C prior to HPLC analysis.
Conversion of [3H]NDP to [3H]NTP—1321N1 cells were incubated in
the presence of ATP and with various concentrations of ADP or UDP
and 0.1–0.5 mCi of [3H]ADP or [3H]UDP to provide a range of specific
radioactivities of the nucleotides. The conversion of [3H]ADP to
[3H]ATP and [3H]UDP to [3H]UTP was determined by HPLC analysis.
Synthesis of [3H]ADP and [3H]UDP—[3H]ADP and [3H]UDP were
obtained from their respective 3H-labeled nucleotide triphosphates by a
hexokinase-catalyzed reaction as described previously (20). Briefly,
20–50 mCi of either [3H]ATP or [3H]UTP (40–50 Ci/mmol) were incu-
bated with 10 units/ml hexokinase for 30 min at 37 °C in 0.2 ml of
DMEM-H/HEPES, pH 7.4. After incubations, the samples were boiled
for 1 min to eliminate the hexokinase activity. Full conversion of
[3H]NTP to [3H]NDP was confirmed by HPLC.
Transfer of the g-Phosphate of [g-33P]ATP to UDP, GDP, CDP, and
TDP—1321N1 cells were washed and incubated as above in 0.5 ml of
DMEM-H/HEPES medium in the presence of 300 mM [g-33P]ATP and
100 mM of the various nucleoside diphosphates. The transfer of
[g-33P]ATP was determined by HPLC analysis.
Determination of the Distribution of Extracellular NDPK Activity—
Two sets of confluent 1321N1 cells grown on 24-well plates were washed
three times and bathed in 0.5 ml of DMEM-H/HEPES. After 1 min at
37 °C the medium from one set of cells was collected, rapidly centri-
fuged to remove any detached cells, and transferred to a tube containing
0.5 mCi of [3H]ADP (50 nmol) and ATP (150 nmol). [3H]ADP and ATP
also were added to the second set of cells, and the NDPK activity of the
medium and cells was assayed for 1 min. Total cellular activity of
NDPK was also determined. Cells from 4 wells cultured in a separate
24-well plate were trypsinized, washed twice, resuspended in 2 ml of 50
mM ice-cold Tris, pH 7.2, and sonicated. NDPK activity was assayed in
a 1:30 dilution of the cell sonicate.
Measurement of Ecto-nucleotidase Activity—1321N1 cells were
washed and incubated in 0.5 ml of DMEM-H/HEPES in the presence of
0.5 mCi and the indicated concentrations of [3H]ADP, [3H]UDP,
[3H]ATP, or [3H]UTP. Since preliminary experiments indicated that
1321N1 cells avidly transport adenosine but not uridine, studies of
[3H]ADP and [3H]ATP hydrolysis were carried out in the presence of the
nucleoside transport inhibitor dipyridamole (100 mM). Dipyridamole did
not affect the rate of hydrolysis of ATP or ADP by 1321N1 cells (data not
shown).
HPLC Separation of Nucleotides—Nucleotides were separated and
quantified by HPLC (Shimadzu) via a Hypersil-SAX column (Bodman,
Aston, PA) using a 30-min linear gradient developed from 5 mM
NH4H2PO4, pH 2.8, to 0.75 M NH4H2PO4, pH 3.7. Absorbance at 264 nm
was monitored with an SPD-10A UV detector (Shimadzu), and radio-
activity was determined on-line with a Flo-One Radiomatic b detector
(Packard, Canberra, Australia) as described previously (21).
Reagents—All nucleoside triphosphates were purchased from Phar-
macia (Uppsala, Sweden). Hexokinase, ouabain, tetramisol, Ap5A,
ADP, UDP, GDP, and CDP were from Boehringer Mannheim. Dipyri-
damole and TDP were from Sigma. Vitrogen was from Collagen Corp.,
Palo Alto, CA. Fura-2/AM and Ca21 buffer were from Molecular Probes
(Eugene, OR). [3H]ATP (40 Ci/mmol), [3H]UTP (50 Ci/mmol), and
[g-33P]ATP (3000 Ci/mmol) were from Amersham.
RESULTS
Our initial evidence that extracellular NDPK activity is as-
sociated with 1321N1 human astrocytoma cells emanated from
studies of the cloned P2Y4 receptor stably expressed in these
cells. We (18) and others (22, 23) originally reported that,
although much less potent than UTP (EC50 5 0.4 mM), ATP
(EC50 5 30 mM) nonetheless was an agonist in 15–20-min
assays of inositol phosphate accumulation in P2Y4 receptor-
expressing 1321N1 cells. However, contrasting results were
obtained in studies of Ca21 mobilization by Nguyen et al. (24),
and we have confirmed their results here. Addition of 1 mM UTP
to Fura-2-loaded P2Y4 receptor-expressing 1321N1 cells re-
sulted in rapid mobilization of intracellular Ca21 (Fig. 1, upper
tracing). In contrast, neither 1 mM UDP (in the presence of
hexokinase) nor 10 mM ATP elevated intracellular Ca21 levels.
However, a small response to UDP was observed if hexokinase
was not added to the cells (Fig. 1, lower tracing). Moreover,
combined addition of 1 mM UDP and 10 mM ATP resulted in a
slowly occurring but sustained increase in intracellular Ca21
(Fig. 1, lower tracing). Taken together these results suggested
that the stimulatory effects at the P2Y4 receptor of the com-
bined presence of UDP and ATP occurred as a consequence of
formation of UTP by an endogenous transphosphorylating ac-
tivity. Because 1321N1 cells readily release ATP upon mechan-
ical stimulation (21), the small effect of UDP in the absence of
FIG. 1. Effects of UDP and ATP on [Ca21]i in P2Y4 receptor-
expressing 1321N1 cells. Changes in [Ca21]i were measured in
Fura-2 preloaded cells in response to 1 mM UTP or 10 mM ATP or in
response to 1 mM UDP added subsequent to the addition of 1 unit/ml
hexokinase (upper panel) or the sequential addition of 1 mM UDP and 10
mM ATP (bottom panel). Stock solutions of UDP (1 mM) were made
UTP-free by preincubation with 10 units/ml hexokinase followed by
boiling for 1 min as previously reported (20). The results are represent-
ative of at least three different experiments.
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hexokinase might reflect formation of UTP from endogenous
ATP.
To determine whether NDPK activity could be detected more
directly, P2Y4 receptor-expressing cells were incubated with
either 1 mM [3H]ADP or 1 mM [3H]UDP in the absence or
presence of 10 mM ATP, and the formation of [3H]ATP or
[3H]UTP was assessed by HPLC. In the absence of added ATP,
the radiolabeled nucleoside diphosphates were partially con-
verted to the corresponding labeled nucleoside monophos-
phates, and no formation of 3H-labeled nucleoside triphosphate
was detected (Fig. 2). In contrast, in the presence of 10 mM ATP,
[3H]ADP and [3H]UDP were converted to their respective nu-
cleoside triphosphates with little evidence of formation of the
monophosphate species.
Conversion of nucleoside diphosphates to triphosphates by
transfer of g-phosphate was confirmed in experiments carried
out with [g-33P]ATP. Incubation of 1321N1 cells with
[g-33P]ATP and UDP or GDP resulted in the rapid formation of
[g-33P]UTP or [g-33P]GTP, respectively (Fig. 3). Thus, a highly
active NDPK activity is associated with the extracellular envi-
ronment of 1321N1 cells. This activity is not a result of over-
expression of the P2Y4 receptor in 1321N1 cells, since in the
presence of 100 mM [3H]ADP and 300 mM ATP similar formation
of [3H]ATP was observed with wild type cells (5.1 6 0.7 nmol/
106 cells/min), P2Y2 receptor-expressing cells (4.4 6 0.2 nmol/
106 cells/min), and P2Y4 receptor-expressing cells (2.7 6 0.6
nmol/106 cells/min).
Time course experiments indicated that in the presence of
unlabeled ATP, 10 mM [3H]ADP was rapidly phosphorylated to
[3H]ATP, and a maximal conversion (approximately 60%) oc-
curred within 2 min after drug addition to 1321N1 cells (Fig.
4A). Under the same conditions the rate of formation of
[3H]UTP was slower than was the formation of [3H]ATP (Fig.
4A), and a maximal conversion of approximately 30% occurred
within 20 min. We have reported previously that relatively
large amounts of endogenous ATP are released from 1321N1
cells upon mechanical stimulation (21). Addition of [3H]ADP or
[3H]UDP to mechanically stimulated 1321N1 cells also re-
FIG. 2. HPLC analysis of metabolic products of [3H]ADP and
[3H]UDP. P2Y4 receptor-expressing 1321N1 cells were washed and
preincubated for 1 h in 0.5 ml of serum-free medium and subsequently
incubated in the presence of 1 mM [3H]ADP (0.5 mCi) (A, B, and C) or in
the presence of 1 mM [3H]UDP (0.2 mCi) (D, E, and F). Panels A and D
represent results from samples containing nonmetabolized 3H-nucleo-
tides (t 5 0); B and E are results from samples incubated for 20 min, and
C and F are from incubations carried out for 5 min in the presence of 10
mM ATP. 3H-Labeled species were separated by HPLC as indicated
under “Materials and Methods.” The retention times for various stand-
ards of adenine and uridine nucleosides and nucleotides are indicated
with arrows. The results are representative of at least four independent
experiments performed in duplicate under similar conditions.
FIG. 3. Transference of the g-phosphate of ATP to UDP and
GDP. 1321N1 cells were incubated for 10 min with 100 mM [g-33P]ATP
(0.5 mCi) alone (A) or in the presence of 100 mM UDP (B) or GDP (C).
g-33P-Labeled species were separated by HPLC as detailed under “Ma-
terials and Methods.” The results are representative of two experiments
performed in duplicate.
FIG. 4. Time course for the conversion of [3H]ADP to [3H]ATP
and [3H]UDP to [3H]UTP. 1321N1 cells were washed, preincubated
for 1 h in 0.5 ml of DMEM-H/HEPES, and further incubated for the
indicated times in the presence of 10 mM (0.5 mCi) [3H]ADP (l) or
[3H]UDP (f). The NDPK activity was assayed in the presence of exog-
enous 10 mM ATP (A) or after the release of endogenous ATP was
promoted by a medium change (B). 3H-Labeled species were quantified
by HPLC as indicated under “Materials and Methods.” The data repre-
sent the mean of two experiments performed with duplicate samples
differing by less than 20%.
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sulted in rapid formation of [3H]ATP or [3H]UTP (Fig. 4B), and
the extent of formation of ATP was greater than that of UTP.
Observation of rapid conversion of extracellular ADP to ATP
and of UDP to UTP by intact 1321N1 cells under conditions in
which nucleotide released from cells serves as a g-phosphate
donor suggests that NDPK activity is important at pharmaco-
logically relevant concentrations of nucleotides. For example,
in the presence of endogenously released ATP, addition of 10
mM UDP (to 0.5 ml of medium bathing 0.3 3 106 cells) resulted
in accumulation of approximately 0.3 mM UTP (Fig. 4B), a
concentration that markedly activates the P2Y2 (21) and P2Y4
(18) receptors.
The concentration dependence for ADP and UDP for promo-
tion of NDPK activity was determined in the presence of a
near-saturating concentration (300 mM) of ATP. Assays were
carried out under apparently initial rate conditions where
,10% of the diphosphate was converted to the corresponding
triphosphate. Conversion of [3H]UDP to [3H]UTP by 1321N1
cells occurred with Vmax(app) and Km(app) values that were ap-
proximately one-half and two-fold, respectively, the values ob-
tained in analogous experiments examining the conversion of
[3H]ADP to [3H]ATP (Fig. 5A and Table I). UDP inhibited the
ATP-promoted formation of [3H]ATP from [3H]ADP and ADP
inhibited the ATP-promoted formation of [3H]UTP from
[3H]UDP (Table II). Furthermore, 50 mM UDP caused an ap-
proximately 3-fold shift to the right of the concentration effect
curve for ADP but had no effect on the Vmax(app) for ADP (data
not shown). The concentration dependence for ATP also was
determined in the presence of a fixed concentration (100 mM) of
[3H]ADP (Fig. 5B). The observed Km(app) for ATP was 4–7-fold
higher than the values determined for the nucleoside diphos-
phates (Table I).
EDTA (5 mM) completely inhibited the conversion of
[3H]ADP to [3H]ATP whereas 5 mM EGTA had no effect (data
not shown). These results suggest that the ecto-NDPK activity
is Mg21-dependent. Ap5A, a well characterized inhibitor of
adenylate kinase (25), had no effect on the conversion of
[3H]ADP to [3H]ATP, suggesting that adenylate kinase activity
does not contribute in the conversion of diphosphates to
triphosphates by 1321N1 cells.
The substrate selectivity of the NDPK activity was deter-
mined for both nucleoside triphosphates and nucleoside diphos-
phates (Table III). GTP and ATP were equally effective in
promoting conversion of [3H]ADP to [3H]ATP, whereas a sig-
nificantly slower rate of phosphorylation of [3H]ADP was ob-
tained with CTP (30–40% relative to ATP). GDP and ADP also
were preferred acceptor substrates relative to CDP (Table III).
The localization of the extracellular NDPK activity also was
determined. Approximately 70% of the total extracellularly
measured NDPK activity was associated with the cell surface of
1321N1 cells (Fig. 6). An approximate doubling of medium
NDPK activity occurred over a 60-min period after an extensive
wash (rapid change of the medium three times) of 1321N1 cells
(data not shown). Under no conditions did medium NDPK
activity approximate that of cell surface NDPK activity. The
total cellular NDPK activity (determined as described under
“Materials and Methods”) was approximately 10-fold higher
than the total activity associated with the cell surface (data not
shown).
The role of ecto-nucleotidases in the metabolism of extracel-
lular adenine nucleotides has been widely studied in various
tissues. In light of the ecto-NDPK activity found associated
with 1321N1 cells, comparative experiments were carried out
measuring the rates of hydrolysis of extracellular nucleoside
tri- and diphosphates. Since essentially all analyses of ecto-
FIG. 5. Substrate dependence for the conversion of 3H-nucleo-
side diphosphates to 3H-nucleoside triphosphates. 1321N1 cells
were incubated in the presence of 300 mM ATP and the indicated
concentrations of [3H]ADP (0.5 mCi) or [3H]UDP (0.5 mCi) (A) or in the
presence of the indicated concentrations of ATP and 100 mM [3H]ADP
(0.5 mCi) (B). The rates of formation of 3H-nucleoside triphosphates
determined by HPLC are expressed as nmol/min/million cells and were
obtained from incubations in which less than 10% of the [3H]diphos-
phate was converted to [3H]triphosphate. The data are the mean value
from a single experiment performed with duplicate samples differing by
less than 20%. Similar results were obtained with at least three inde-
pendent experiments performed under the same conditions.
TABLE I
Kinetic constants for the NDPK activity of 1321N1 cells
Concentration-response curves were generated under conditions that
approximated first order rates of reaction, i.e. one substrate was main-
tained at a near maximally effective concentration whereas the concen-
tration of the second nucleotide was varied as detailed in Fig. 5. Data
were obtained from incubations resulting in less than 10% conversion of
3H-nucleoside diphosphate to 3H-nucleoside triphosphate. The data
were fitted to a hyperbolic function, and the parameters were calculated
utilizing a Sigma Plot software (Jandel). The results represent the




ATP 92.7 6 8.1 4.2 6 0.6
ADP 17.4 6 3.8 3.7 6 0.4
UDP 37.0 6 6.7 2.3 6 0.3
TABLE II
Substrate competition for NDPK activity
The conversion of 100 mM [3H]ADP to [3H]ATP was assayed in the
absence or in the presence of 100 mM UDP, and the conversion of 100 mM
[3H]UDP to [3H]UTP was assayed in the absence or in the presence of
100 mM ADP. Incubations were for 20 min. The results are expressed as
nanomoles of [3H]NTP formed per well (mean 6 S.D., n 5 4).
Addition None ADP UDP
[3H]ADP 32.5 6 1.0 24.2 6 0.7
[3H]UDP 11.5 6 0.6 5.3 6 0.9
Ecto-nucleoside Diphosphokinase 20405
nucleotidases to date have focused on the hydrolysis of adenine
nucleotides, we also determined the relative effectiveness of
1321N1 cells for hydrolysis of extracellular uridine nucleotides.
Extracellular [3H]ATP (1 mM) was hydrolyzed (Fig. 7) by
1321N1 cells with a half-time of approximately 25 min (in a
volume of 500 ml on a 1-cm2 well of a 12-well dish). The time
courses of disappearance of UTP, ADP, and UDP were essen-
tially superimposable with that observed for ATP (Fig. 7). The
similarity of adenine and uridine nucleotide tri- and diphos-
phates as substrates for ecto-nucleotidase activity was con-
firmed in kinetic experiments. Thus, the observed Km and Vmax
values for all four molecules were very similar (Table IV). This
nucleotidase activity was unchanged in the presence of 2 mM
ouabain (a P-type ATPase inhibitor), 5 mM tetramisol (an al-
kaline phosphate inhibitor), 10 mM NaN3 (a mitochondrial
ATPase inhibitor), or 10 mM NaF (a nonspecific inhibitor of
phosphatase), but it was abolished by chelators of Ca21/Mg21
(data not shown). The similarity of the kinetic constants calcu-
lated for nucleotidase activity against the four adenine and
uridine nucleotides and the lack of inhibitory effects of several
ATPase and phosphatase inhibitors suggest that the nucleotid-
ase activity is an apyrase type, i.e. it is an ATP-diphosphohy-
drolase (8, 9, 26). The results obtained in kinetic analysis of the
nucleotidase activity of 1321N1 cells also were consistent with
the data illustrated in Fig. 2, B and C. That is, the NDPK
activity associated with 1321N1 cells would be expected to
exceed the ecto-nucleotidase activity by up to 20-fold in the
presence of low micromolar concentrations of nucleoside
diphosphate and an excess concentration of a g-phosphate-
donating nucleoside triphosphate.
DISCUSSION
This study identifies an ecto-NDPK activity associated with
the extracellular surface of 1321N1 cells. Transphosphorylat-
ing activity apparently emanates from a single enzymatic spe-
cies that utilizes either ADP or UDP similarly well as sub-
strates for formation of the corresponding triphosphate.
TABLE III
Substrate specificity for NDPK activity
Upper, confluent 1321N1 cells grown on 12-well plastic plates were
incubated for 10 min in 0.5 ml of DMEM-H/HEPES with 100 mM
[3H]ADP and 300 mM of the indicated nucleoside triphosphates. Bottom,
cells were incubated for 10 min with 100 mM GDP, UDP, or CDP and
with 300 mM [g-33P]ATP or with 100 mM [3H]ADP and 300 mM unlabeled
ATP. Conversions of [33P]ATP to other 33P-nucleoside triphosphates
and [3H]ADP to [3H]ATP were quantified by HPLC as described under
“Materials and Methods.” The results are expressed as percent of
NDPK activity relative to ATP (upper) or ADP (bottom), and the num-
bers in parentheses indicate the net activity in nmol/well. The results





GTP 103 6 1 (33)
dATP 90 6 2 (29)
UTP 77 6 9 (28)
dGTP 72 6 2 (23)
CTP 34 6 1 (11)
ADP 100 (32)
GDP 109 6 1 (35)
UDP 82 6 2 (26)
TDP 56 6 3 (18)
CDP 39 6 6 (12)
FIG. 6. Distribution of extracellular NDPK activity. The conver-
sion of [3H]ADP to [3H]ATP was measured in medium bathing cells
(hatched bar) or in cell-free medium (open bar) collected from surface
cultures of 1321N1 cells as described under “Materials and Methods.”
The data (mean 6 S.D., n 5 3) are representative of results from two
different experiments.
FIG. 7. Hydrolysis of 3H-nucleotides by 1321N1 cells. Confluent
1321N1 cells grown on 24-well plastic plates were incubated in 0.5 ml of
serum-free DMEM-H/HEPES in the presence of 1 mM (0.5 mCi) [3H]ATP
(l), [3H]UTP (f), [3H]ADP (å), or [3H]UDP (ç). Reactions were termi-
nated at the times indicated, and the 3H-labeled species were quantified
by HPLC. Inset, the hydrolysis of [3H]ATP (l) and [3H]ADP (å) was
measured at different substrate concentrations, and values for the
initial rates of hydrolysis were determined as detailed in legend of Fig.
5. The data represent the mean of at least two different experiments
performed with duplicate samples which differed by less than 20%.
TABLE IV
Kinetic constants for the ecto-nucleotidase activity of 1321N1 cells
Concentration-response curves were generated from incubations in
which less than 10% of 3H-labeled substrate was converted to its hy-
drolysis products (as in Fig. 7, inset). The data were fit to a hyperbolic
function, and values for constants were calculated utilizing a Sigma
Plot software. Km and Vmax values are expressed in mM and nmol min
21
cells 31026, respectively. The results are the mean 6 S.D. from three
experiments performed in duplicate.
Km Vmax
mM nmol/min/106 cells
ATP 66 6 13 0.8 6 0.3
UTP 87 6 11 0.6 6 0.1
ADP 90 6 17 0.9 6 0.2
UDP 122 6 34 1.1 6 0.2
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Although formation of ATP from ADP can be effected by ad-
enylate kinase (2ADP 3 ATP 1 AMP), no evidence for the
occurrence of this reaction was detected. Moreover, the rate of
transfer of [g-33P]phosphate from extracellular ATP to nucleo-
side diphosphates approximated the rates of conversion of 3H-
labeled nucleoside diphosphates to nucleoside triphosphates.
Therefore, the majority of this conversion must occur due to an
extracellular NDPK activity.
The observed NDPK activity is not trivial. Indeed, kinetic
analyses of the NDPK and nucleotidase activities indicated
that at relatively low diphosphate concentrations the NDPK
activity exceeds that of the extracellular nucleotidase activity
by up to 20-fold. This calculated surfeit of NDPK activity rel-
ative to nucleotidase activity was confirmed directly. That is,
addition of [3H]ADP or [3H]UDP to the medium of 1321N1 cells
in the presence of ATP resulted in relatively large formation of
the corresponding radiolabeled triphosphates with little evi-
dence of conversion of the diphosphates to monophosphates.
The extracellular NDPK activity is largely, but not exclu-
sively, found as a surface membrane-associated ectoenzyme
rather than as an enzymatic activity in the extracellular me-
dium. The identity of this extracellular NDPK is not yet clear.
Two putative tumor suppressor genes, nm23-H1 and mm23-
H2, have been cloned and shown to encode for approximately
17-kDa proteins (also called NDPK A and NDPK B) that ex-
hibit NDPK activity (14, 15). It is unclear whether these en-
zymes account for all of the intracellular NDPK activity, and
we have not yet addressed whether the ecto-NDPK activity is
the same species as the previously molecularly identified forms
of NDPK activity.
Extracellular NDPK has functional significance in 1321N1
cells. Although kinetic analyses required addition of known
amounts of nucleoside triphosphate to the medium, substantial
conversion of radiolabeled diphosphate to triphosphate oc-
curred under conditions, e.g. a change of medium, in which ATP
is released from 1321N1 cells (21). Thus, the released triphos-
phate readily serves as a g-phosphate donor for exogenously
added nucleoside diphosphates. Such interconversion of nucle-
otides also has a major influence on pharmacological effects
observed with exogenously applied nucleotide agonists. Thus,
as was illustrated in Fig. 1, UDP in the absence but not in the
presence of hexokinase raised Ca21 in P2Y4 receptor-express-
ing 1321N1 cells. Coaddition of UDP with ATP resulted in a
marked Ca21 response. Thus, observations (22, 24) indicating
that UDP was an agonist at the P2Y4 receptor expressed in
1321N1 cells likely were due to conversion of UDP to UTP in
the presence of released endogenous ATP during the 15–20-
min measurements of inositol phosphate accumulation. Simi-
larly, we have shown that the full agonist effects that we and
others originally reported for UDP and ADP at the P2Y2 recep-
tor could be at least in part due to NDPK-promoted conversion
of these diphosphates to their corresponding triphosphates (18,
21), which are potent full agonists at the P2Y2 receptor. We
also have reported that since hexokinase in the presence of
glucose converts ATP and UTP to their corresponding diphos-
phates, this enzyme can be included in the medium in experi-
ments designed to determine the pharmacological effects of
nucleoside diphosphates (18, 20), a strategy that blocked the
UDP effect on Ca21 in P2Y4 expressing cells (Fig. 1). Since
1321N1 cells represent the principle null cell line in which P2Y
receptors have been expressed, the presence of a heretofore
unrecognized ecto-NDPK activity on these cells may explain in
large part the discrepant results reported by various laborato-
ries in studies of the pharmacological selectivities of these
receptors.
Not only is the ecto-NDPK similarly active against adenine
and uridine nucleotide substrates, but our results indicate that
the ecto-nucleotidase activity of 1321N1 cells also hydrolyzes
uridine nucleotides at rates similar to that observed with ade-
nine nucleotides. Thus, the extracellular hydrolytic machinery
that has been widely studied and established as an important
component of the extracellular adenine nucleotide signaling
apparatus likely has a similarly important role in terminating
the action of extracellular uridine nucleotides. Identification of
an ecto-NDPK activity that is equally active against adenine
and uridine nucleotides now adds a second level of complexity
in understanding the physiological roles of adenine and uridine
nucleotides as extracellular signaling molecules.
Although the data presented here have arisen entirely from
studies of 1321N1 cells, the extracellular conversion of diphos-
phates to triphosphates is not restricted to this tumor cell line.
For example, we have observed similar extracellular intercon-
version of nucleotides in studies of polarized human airway
epithelial cells that maintain many of the phenotypical char-
acteristics associated with these cells in vivo (20). Whether
extracellular NDPK activity is expressed in a cell- or tissue-
specific manner will need to be established. The occurrence of
extracellular levels of enzyme activity similar to those observed
with 1321N1 cells would have major physiological significance
in regulating the extracellular signaling properties of adenine
and uridine nucleotides.
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